Maxwellia is ready to market its Lovima daily contraceptive as a non-prescription brand if its application to switch the progestogen-only pill (POP) in the UK is approved, representing a leap forward for the company. CEO Anna Maxwell tells HBW Insight about Maxwellia's journey from R&D start-up to consumer health player.
Maxwellia is one of two firms on the cusp of offering an OTC oral contraceptive in the UK.
Alongside France’s HRA Pharma, the British start-up is now eagerly awaiting the outcome of the UK Medicines and Healthcare products...
Create an account to read this article
Already a subscriber?
Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.
Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.
Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.
HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.
HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.
What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.
Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.
